Myeloma and Immunology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Immunology and Immunotherapy".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 2
Special Issue Editor
2. Myeloma & Lymphoma Research Group, Champalimaud Foundation, Lisbon, Portugal
3. NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal
Interests: immune microenvironment in multiple myeloma; application of fundamental immunological concepts and discoveries for treatment of hematological malignancies; liquid biopsies as biomarkers for diagnosis and disease progression; ex vivo ways to perform biological studies and drug testing using 3D organoids
Special Issue Information
Dear Colleagues,
Multiple myeloma (MM) is a complex hematologic malignancy characterized by the uncontrolled proliferation of clonal plasma cells and profound immune dysregulation. Advances in our understanding of the tumor microenvironment, immune escape mechanisms, and immune system dysfunction have not only deepened insights into MM pathogenesis but also opened new avenues for therapeutic intervention. The interplay between malignant plasma cells and the immune system has emerged as a crucial determinant of disease progression, prognosis, and treatment response, particularly in the era of immunotherapy, involving monoclonal antibodies, CAR-T cells, bispecific T-cell engagers, and immune checkpoint inhibitors.
We are pleased to invite researchers and clinicians working in cancer biology, hematology, and immunotherapy to contribute to this Special Issue titled “Myeloma and Immunology”, aligning with Cancers' mission to disseminate high-impact oncology research with clinical relevance.
This Special Issue aims to gather original research articles and comprehensive reviews that explore the immunological landscape of multiple myeloma. Research areas may include (but are not limited to) the following: immune profiling, immunogenomics, novel immunotherapies, mechanisms of resistance, and the role of the bone marrow niche in immune regulation. By fostering cross-disciplinary contributions, this Special Issue seeks to advance the translational impact of immunology in MM research and clinical care.
We look forward to receiving your contributions.
Dr. Joao Cristina
Guest Editor
Dr. Joana Caetano
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple myeloma
- tumor immunology
- immune microenvironment
- immunotherapy
- CAR-T cells
- immune evasion
- immune profiling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
